03-Mar-2014 - Criminal access to APIs must be cut off in a way that does not infringe generics companies’ right to buy chemicals, a top US prosecutor told In-Pharmatechnologist.com.
News in brief
27-Feb-2014 - BASF has hiked its prices for ethanolamines in Europe citing continuous demand increase.
26-Feb-2014 - Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
25-Feb-2014 - FMC has hired Connell Brothers (CBC) to distribute its drug excipients in Japan, citing the move as a key step to building its business in the country.
25-Feb-2014 - Ranbaxy has temporarily halted all shipments from two API plants currently under a US FDA consent decree, although both the firm and an analyst say a shortage is unlikely.
20-Feb-2014 - Four more drug excipient suppliers have been certified under the newly independent Excipact quality scheme.
17-Feb-2014 - AMRI says it intends to expand its API business to target both generics and more complex molecules after reporting record full year revenue from contract services.
17-Feb-2014 - Sinopharm expects customer drug launches and its recent investment in cancer injectables to drive revenue gains and margin growth in 2014.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.